Publishing Department： Marketing Department

The German metabolic clinical research institute Profil and Genya Biotech Co., Ltd. presented at ADA’s 83rd Scientific Sessions with the poster subject "GN1101DP, Genova’s biosimilar insulin lispro, demonstrates pharmacokinetic (PK) and pharmacodynamic (PD) bioequivalence with Eli Lilly Humalog® in healthy Caucasian and Chinese subjects". This clinical trial is the first comparison study of PK and PD between Caucasian and Chinese subjects in strict accordance with the current EMA insulin guidelines.

Dr. Tim Heise (Chief Scientist of Profil ) and Dr. Shen (Chief Scientist of Genova) answered questions from 11:30 to 12:30 on June 24 2023, and had an in-depth exchanges of view with many senior experts in the field of insulin and diabetes.

Poster’s Position: 83rd ADA Poster Presentations: Clinical Diabetes/Therapeutics, P: Clinical Therapeutics-Insulins, 820-P

Exhibition Time: 2023.6.23-2023.6.26